Industries > Pharma > Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029

Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029

Suspension Aerosol, Solution Aerosol, Dry Powder Formulation, Metered Dose Inhalers (MDIS), Dry Powder Inhalers (DPIS), Nebulizers, Accessories, Plain Canister, Coated Canister, Asthma, COPD, Cystic Fibrosis, Other Applications, Hospitals & Clinics, Homecare Settings

PUBLISHED: 29 May 2019
PAGES: 155
PRODUCT CODE: PHA0371
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0371 Categories: , Tags: ,

The global pulmonary/respiratory drug delivery market reached $40.67 bn in 2018 and is expected to grow at a CAGR of 7.60% in 2019-2024. The MDIs segment is estimated to hold a share of 62.4% in 2018. Increasing prevalence and incidence of chronic respiratory diseases is a major factor that is expected to drive the growth of this market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 155-page report you will receive 70 tables and 84 figures– all unavailable elsewhere.

The 155-page report provides clear detailed insight into the global pulmonary/respiratory drug delivery market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029

• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by Product:
– Formulation: Suspension Aerosol. Solution Aerosol, Dry Powder Formulation
– Devices: Metered Dose Inhalers (MDIS), Dry Powder Inhalers (DPIS), Nebulizers, Accessories

• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by Canister Type:
– Plain Canisters
– Coated Canister

• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by Application:
– Asthma
– COPD
– Cystic Fibrosis
– Other Applications

• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by End-User:
– Hospitals & Clinics
– Homecare Settings

• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2018-2029 by regional and national market:
– North America (US, Canada)
– Europe (Germany, UK, France, Italy, Spain)
– Asia-Pacific (Japan, China, India, Australia, Malaysia)
– RoW (Brazil, Mexico, Turkey, South Africa, Argentina)

• Profiles of the selected leading companies:
– 3M Health Care
– AstraZeneca
– Boehringer Ingelheim GmbH
– GlaxoSmithKline PLC
– Merck & Co., Inc.
– Novartis AG
– OMRON Corporation
– Philips Respironics
– Sunovion Pharmaceuticals Inc.
– Teva Pharmaceutical

• Qualitative analysis of the global pulmonary/respiratory drug delivery market. Discussion on trends, factors that drive and restrain the market as well as Porter’s Five Forces Analysis.

• Key Questions Answered by this Report:
– What are the global revenue prospects for the period 2018 to 2029?
– What are the leading national market potentials from 2018 to 2029?
– How is the respiratory drug delivery market evolving?
– What is driving and restraining the respiratory drug delivery market?
– What are the market shares of each segment of the overall respiratory drug delivery market?
– How will main respiratory drug delivery submarket segments develop over the forecast period and how much revenue will these submarkets account for in 2029?
– How will the market shares for each respiratory drug delivery submarket develop from 2018 to 2029?
– What will be the main commercial drivers for the market from 2018 to 2029?
– How will political and regulatory factors influence that industry and its submarkets?
– How will market shares of prominent national markets change from 2018, and which countries will lead the market in 2029, achieving highest revenues and fastest growth?

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Pulmonary/Respiratory Drug Delivery Market. You find data, trends and predictions.

Buy our report today Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029: Suspension Aerosol, Solution Aerosol, Dry Powder Formulation, Metered Dose Inhalers (MDIS), Dry Powder Inhalers (DPIS), Nebulizers, Accessories, Plain Canister, Coated Canister, Asthma, COPD, Cystic Fibrosis, Other Applications, Hospitals & Clinics, Homecare Settings.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category